Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

RNA Sequencing of Trigeminal Ganglia in Rattus Norvegicus after Glyceryl Trinitrate Infusion with Relevance to Migraine.

Hougaard Pedersen S, Maretty L, Ramachandran R, Sibbesen JA, Yakimov V, Elgaard-Christensen R, Hansen TF, Krogh A, Olesen J, Jansen-Olesen I.

PLoS One. 2016 May 23;11(5):e0155039. doi: 10.1371/journal.pone.0155039. eCollection 2016.

2.

Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens.

Hebeisen M, Allard M, Gannon PO, Schmidt J, Speiser DE, Rufer N.

Front Immunol. 2015 Nov 18;6:582. doi: 10.3389/fimmu.2015.00582. eCollection 2015. Review.

3.

The immunogenetics of multiple sclerosis: A comprehensive review.

Hollenbach JA, Oksenberg JR.

J Autoimmun. 2015 Nov;64:13-25. doi: 10.1016/j.jaut.2015.06.010. Epub 2015 Jul 2. Review.

4.

T Cells: Soldiers and Spies--The Surveillance and Control of Effector T Cells by Regulatory T Cells.

Hall BM.

Clin J Am Soc Nephrol. 2015 Nov 6;10(11):2050-64. doi: 10.2215/CJN.06620714. Epub 2015 Apr 15. Review.

5.
6.

Co-evolution of human leukocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors (KIR) in a genetically diverse population of sub-Saharan Africans.

Norman PJ, Hollenbach JA, Nemat-Gorgani N, Guethlein LA, Hilton HG, Pando MJ, Koram KA, Riley EM, Abi-Rached L, Parham P.

PLoS Genet. 2013 Oct;9(10):e1003938. doi: 10.1371/journal.pgen.1003938. Epub 2013 Oct 31.

7.

β2-Microglobulin-mediated signaling as a target for cancer therapy.

Nomura T, Huang WC, Zhau HE, Josson S, Mimata H, Chung LW.

Anticancer Agents Med Chem. 2014 Mar;14(3):343-52. Review.

8.

Extracellular domains of CD8α and CD8ß subunits are sufficient for HLA class I restricted helper functions of TCR-engineered CD4(+) T cells.

van Loenen MM, Hagedoorn RS, de Boer R, Falkenburg JH, Heemskerk MH.

PLoS One. 2013 May 30;8(5):e65212. doi: 10.1371/journal.pone.0065212. Print 2013.

9.

Opposing chemokine gradients control human thymocyte migration in situ.

Halkias J, Melichar HJ, Taylor KT, Ross JO, Yen B, Cooper SB, Winoto A, Robey EA.

J Clin Invest. 2013 May;123(5):2131-42. doi: 10.1172/JCI67175. Epub 2013 Apr 15.

10.

Islet-specific CTL cloned from a type 1 diabetes patient cause beta-cell destruction after engraftment into HLA-A2 transgenic NOD/scid/IL2RG null mice.

Unger WW, Pearson T, Abreu JR, Laban S, van der Slik AR, der Kracht SM, Kester MG, Serreze DV, Shultz LD, Griffioen M, Drijfhout JW, Greiner DL, Roep BO.

PLoS One. 2012;7(11):e49213. doi: 10.1371/journal.pone.0049213. Epub 2012 Nov 14.

11.

Effective elicitation of human effector CD8+ T Cells in HLA-B*51:01 transgenic humanized mice after infection with HIV-1.

Sato Y, Nagata S, Takiguchi M.

PLoS One. 2012;7(8):e42776. doi: 10.1371/journal.pone.0042776. Epub 2012 Aug 6.

12.

TCR Signaling Emerges from the Sum of Many Parts.

Kuhns MS, Davis MM.

Front Immunol. 2012 Jun 25;3:159. doi: 10.3389/fimmu.2012.00159. eCollection 2012.

13.

Temporal transcriptome changes induced by MDV in Marek's disease-resistant and -susceptible inbred chickens.

Yu Y, Luo J, Mitra A, Chang S, Tian F, Zhang H, Yuan P, Zhou H, Song J.

BMC Genomics. 2011 Oct 12;12:501. doi: 10.1186/1471-2164-12-501.

14.

Phylogenetic and developmental study of CD4, CD8 α and β T cell co-receptor homologs in two amphibian species, Xenopus tropicalis and Xenopus laevis.

Chida AS, Goyos A, Robert J.

Dev Comp Immunol. 2011 Mar;35(3):366-77. doi: 10.1016/j.dci.2010.11.005. Epub 2010 Nov 21.

15.

Failure of effector function of human CD8+ T Cells in NOD/SCID/JAK3⁻/⁻ immunodeficient mice transplanted with human CD34+ hematopoietic stem cells.

Sato Y, Takata H, Kobayashi N, Nagata S, Nakagata N, Ueno T, Takiguchi M.

PLoS One. 2010 Oct 1;5(10). pii: e13109. doi: 10.1371/journal.pone.0013109.

16.

CD4 on the road to coreceptor status.

Vignali DA.

J Immunol. 2010 Jun 1;184(11):5933-4. doi: 10.4049/jimmunol.1090037. Review. No abstract available.

17.

Ca2+ release from the endoplasmic reticulum of NY-ESO-1-specific T cells is modulated by the affinity of TCR and by the use of the CD8 coreceptor.

Chen JL, Morgan AJ, Stewart-Jones G, Shepherd D, Bossi G, Wooldridge L, Hutchinson SL, Sewell AK, Griffiths GM, van der Merwe PA, Jones EY, Galione A, Cerundolo V.

J Immunol. 2010 Feb 15;184(4):1829-39. doi: 10.4049/jimmunol.0902103. Epub 2010 Jan 6.

18.

Structural basis of the CD8 alpha beta/MHC class I interaction: focused recognition orients CD8 beta to a T cell proximal position.

Wang R, Natarajan K, Margulies DH.

J Immunol. 2009 Aug 15;183(4):2554-64. doi: 10.4049/jimmunol.0901276. Epub 2009 Jul 22.

19.

Novel nonclassical MHC class Ib genes associated with CD8 T cell development and thymic tumors.

Goyos A, Ohta Y, Guselnikov S, Robert J.

Mol Immunol. 2009 May;46(8-9):1775-86. doi: 10.1016/j.molimm.2009.01.016. Epub 2009 Feb 23.

20.

T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity.

Stone JD, Chervin AS, Kranz DM.

Immunology. 2009 Feb;126(2):165-76. doi: 10.1111/j.1365-2567.2008.03015.x. Review.

Supplemental Content

Support Center